Hanson McClain Advisors »

Ocuphire Pharma shares owned by Hanson McClain Advisors

Quarter-by-quarter ownership of Ocuphire Pharma (IRD) shares owned by Hanson McClain Advisors from 13F filings

Historical chart of Hanson McClain Advisors investment in Ocuphire Pharma

Tip: Access up to 7 years of quarterly data

All positions including Ocuphire Pharma held by Hanson McClain Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ocuphire Pharma by Hanson McClain Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $11 5 2.20

More positions owned by Hanson McClain Advisors

Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Spdr Series Trust State Street Spd (SPYG)
Spdr Series Trust State Street Spd (SPYV)
Ishares Tr Us Treas Bd Etf (GOVT)
Apple Call Call Option (Principal) (AAPL)
Vanguard Index Fds Mid Cap Etf (VO)
Spdr Index Shs Fds Portfolio Emg Mk (SPEM)
J P Morgan Exchange Traded F Active Bond Etf (JBND)
Gmo Etf Trust Gmo Us Quality E (QLTY)
Ishares Tr Mbs Etf (MBB)
Ishares Tr Usd Inv Grde Etf (USIG)
Ishares Tr Core S&p Ttl Stk (ITOT)

View all positions for Hanson McClain Advisors

Top funds holding Ocuphire Pharma

Nantahala Capital Management
Perceptive Advisors
BIOS Capital Management
Vanguard Group
Mink Brook Asset Management
Opaleye Management
Adage Capital Partners GP
Bleichroeder
Geode Capital Management
Voss Capital
Susquehanna International
Wells Fargo & Company
State Street Corporation
Marshall Wace
BlackRock

View all funds holding Ocuphire Pharma